powered by:
yole développement

Slider home

PositiveID Corporation enters into strategic financing for $4 million

Proceeds to be used to continue development of PositiveID's Firefly Dx handheld rapid diagnostic device.

Read more...

BioMérieux and Illumina enter agreement to co-develop a next-generation sequencing solution for epidemiological monitoring of bacterial infections

BioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an exclusive agreement to launch a next-generation sequencing (NGS) epidemiology solution for service labs. The two companies will jointly develop applications for microbiology sequencing technologies within a four-year renewable period.

Read more...

Tiny needles offer potential new treatment for two major eye diseases

Needles almost too small to be seen with the unaided eye could be the basis for new treatment options for two of the world’s leading eye diseases: glaucoma and corneal neovascularization.

Read more...

Cepheid to develop xpert Ebola for countries worst hit by Epidemic

With Funding from the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, Cepheid Expects to Deliver Prototype in as Little as Eight Weeks.

Read more...

Sensirion wins innovation prize at Compamed 2014 exhibition

Sensirion AG (Switzerland), the leading manufacturer of digital microsensors, has won the DeviceMed OEM-Components innovation prize at the Compamed 2014 exhibition.

Read more...

QTUG quantitative timed up and go system for mobility assessment

The Timed Up and Go test (TUG) is a simple and easy way to assess a person’s mobility and evaluate the chances of experiencing a dangerous fall.

Read more...

LATEST EVENTS

No events
27